CD8A and hepatocellular carcinoma: 4-1BB agonist stimulation exacerbated liver inflammation, leading to fibrosis, cirrhosis and ultimately HCC in HBV transgenic mice, and this effect was mainly mediated by CD8+ T cells (151).